Clinical Trials Directory

Trials / Completed

CompletedNCT04387747

Evaluation of Sarcopenia in Patients With Stroke

Evaluation Of Sarcopenia In Stroke Patients

Status
Completed
Phase
Study type
Observational
Enrollment
81 (actual)
Sponsor
Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Other Government
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the prevalence of sarcopenia in stroke patients; to determine the relationship between sarcopenia and duration of stroke, age, gender, etiology of stroke, ambulation status, spasticity, nutrition and malnutrition

Detailed description

Sarcopenia was defined as a loss of skeletal muscle mass and decreased muscle strength. The purpose of this study was to investigate the prevalence of sarcopenia following stroke, to investigate the relationship between sarcopenia and duration of stroke, age, sex, etiology of stroke, ambulation status, spasticity, nutrition and malnutrition. Demographic characteristics, duration of stroke, sarcopenia presence (walking speed ≥ 0.8 m / s, SARC-F score ≥4, short physical performance battery score ≤ 8, thigh circumference \<33cm (The data for Turkey) \<31cm (European data)) were recorded. Hand grip strength (jamar) measured from the intact hand and TANITA BIA analysis were planned for all patients. Ambulation level with Functional Ambulation Classification (FAC), nutritional status with 24-hour dietary recall (24HR) method, diagnosis of malnutrition with Glim Criteria, spasticity with Modified Ashworth Scale, motor development for stroke patient Brunnstrom staging, screening for frailty with Frail questionnaire activity of daily living were evaluated with Barthel Index.

Conditions

Interventions

TypeNameDescription
OTHERSARCOPENIA IN STROKE PATIENTSDemographic characteristics, duration of stroke, sarcopenia presence,thigh circumference , Hand grip strength , TANITA BIA analysis

Timeline

Start date
2019-09-15
Primary completion
2020-06-01
Completion
2020-06-01
First posted
2020-05-14
Last updated
2020-06-30

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04387747. Inclusion in this directory is not an endorsement.